Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2020
published in
has subject area
- Aged
- Antineoplastic Agents, Immunological
- B7-H1 Antigen
- Betacoronavirus
- COVID-19
- COVID-19 Testing
- CTLA-4 Antigen
- Clinical Decision-Making
- Clinical Laboratory Techniques
- Coronavirus Infections
- Female
- Humans
- Immunosuppressive Agents
- Incidence
- Male
- Medical Oncology
- Middle Aged
- Neoplasms
- New York City
- Pandemics
- Pneumonia, Viral
- Practice Patterns, Physicians'
- Programmed Cell Death 1 Receptor
- Prospective Studies
- Registries
- Rheumatic Diseases
- SARS-CoV-2
- Severity of Illness Index
- Surveys and Questionnaires